1Heinemann V, Moosmann N. Neoadjuvant and adjuvant therpies for solid tumours. MMW Fortschr Med, 2007, 149 (35-36): 27-30.
2Lowy AM, Mansfield PF, Leach SD, et al. Response to neoad juvant chemotherapy best predicts survival after curative resection ofgastric cancer. Ann Surg, 1999, 229 (3): 303-308.
3Wilke H, Preusser P, Fink U, et al. Preoperative chemotherapyin locally advanced and nonresectable gastric cancer:a phase Ⅱ study with etoposide , doxorubicin, and cisplatin. J Clin Oncol, 2000, 7 (9): 1318-1321.
4Elliot-Newman E, Marcus SG, chemotherapy with CPT-11 and Potmesil M, et al. Neoadjuvant cisplatin downstages locally advanced gastriccancer. J Gastrointest Surg, 2002, 6 ( 2 ) 212-223.
5Ott K, Sendler A, Becker K, et al. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) inlocally advanced gastric cancer: aprospective phase Ⅱ study J. Gastric Cancer, 2003, 6 (3): 159-167.
6Persiani R, D'Ugo D, Rausei S, et al. Prognostic indicators in locally dvanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy. J Surg Oncol, 2005, 89(4): 227-236.
7Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a metaanalysis of randomised trials. Eur J Cancer, 1999, 35 (7):1059-1064.
8Gianni L, Panzini I, Tassinari D, et al. Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol, 2001, 12 (8): 1178-1180.
9Falcone A. Future strategies and adjuvant treatment of gastric cancer. Annals of Oncology, 2005, 14 ( Supplement 2 ):1145-1147.
10Hailer. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST):Racing against resistance. Annals of Surgical Ontology, 2007, 14 (4): 1247-1248.
